Remove 2024 Remove Clinic Remove Medical Specialty Remove Patients
article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

FDA Law

We also commend and congratulate the legions of rare disease patient advocates and the leadership of the EveryLife Foundation for Rare Diseases (“ELF”) who championed the advocacy efforts that led to this important milestone. those reviewed by the CDER Division of Rare Diseases and Medical Genetics). By Sarah Wicks & James E.

article thumbnail

Geriatric Medicine Board Meeting Summary | Spring 2025

ABIM

Expanding ABIM’s engagement with stakeholder communities such as early career physicians, specialty societies and patient-focused organizations. The ABIM Council approved the pilot earlier this year and submitted it to the American Board of Medical Specialties, the final approval stage before implementation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

Expanding ABIM’s engagement with stakeholder communities such as early career physicians, specialty societies and patient-focused organizations. This is now being reviewed by the American Board of Medical Specialties, which oversees ABIM.